Gonorrhea linked to higher prostate cancer risk

	Tweet

Men with a history of the sexually transmitted disease gonorrhea may face a higher risk of prostate cancer, a study suggests.

The findings, from a study of more than 800 African-American men, add to evidence that STDs may contribute to the development of prostate cancer. Researchers suspect that chronic inflammation in the prostate gland, caused by infection, may over time promote tumor development.

Of the 40- to 79-year-old men in the current study, those with a history of gonorrhea were 78 percent more likely to develop prostate cancer than men who’d never had the STD.

In addition, men who reported the most sexual partners—25 or more over their lives—had a nearly three times greater risk of the cancer than men who’d had five or fewer partners. This further suggests a role for “sexually transmitted factors” in prostate cancer risk, the researchers report in the Journal of Urology.

Past studies have found associations between STDs and prostate cancer risk in white men. The current study focused on black men, who have significantly higher rates of both prostate cancer and STDs such as gonorrhea.

Taken together, the evidence suggests that a history of STD infection may be a risk factor for prostate cancer, according to lead author Dr. Aruna V. Sarma, an assistant research scientist in urology at the University of Michigan in Ann Arbor.

But to confirm that, she told Reuters Health, researchers need to conduct studies where they not only look at relationships between STD history and prostate cancer risk, but also examine blood and tissue samples for markers of STD infection and chronic inflammation.

If STD infection is indeed a risk factor for prostate cancer, there will be important implications for prevention, according to Sarma.

There are few known modifiable risk factors for prostate cancer, she noted, so the link between the cancer and STDs like gonorrhea needs to be investigated further.

SOURCE: Journal of Urology, September 2006.

RELATED STORIES:
Prostate Cancer: Watchful Wait or Vaccinate?   Folate may alter risk of prostate cancer progression   Annual Prostate Cancer Screening Test Appears to Save Lives   Hormonal Dietary Supplements Might Promote Prostate Cancer Progression   Combination of genetic mutation and viral infection may cause prostate cancer   Dutasteride useful for enlarged prostate   Does age matter in selection of treatment for men with early-stage prostate cancer?   Genetic map of prostate cancer cracked   Prostate Cancer Etiology   Being active may ward off prostate cancer death   Researchers identify promising cancer drug target in prostate tumors   Data Suggests a Diet High in Vegetable Intake Can Reduce Risk of Prostate Cancer   Prostate cancer risk increased in obese men: study   Vitamin D protects cells from stress that can lead to cancer   Gene Markers Located for Hereditary Prostate Cancer   Study Drug Holds Promise As Alternative to Castration For Early Prostate Cancers   Family counseling improves lives of patients and spouses coping with prostate cancer   New prostate cancer imaging shows real-time tumor metabolism   Vaccine Approach Extends Life of Metastatic Prostate Cancer Patients   Moderate exercise may lower prostate cancer risk   Researchers Studying Novel Therapy For Prostate Cancer   Surgical Prospectives in High-Risk Prostate Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]